Now Available: Analgesics in Hungary

Recently published research from Euromonitor International, "Analgesics in Hungary", is now available at Fast Market Research

Logo

Boston, MA -- (ReleaseWire) -- 06/17/2014 --2013 performance of analgesics in Bosnia-Herzegovina was below the review period CAGR of 2% in current value terms. In 2013 the economy performed below previously forecast levels. Consumers' disposable income made no significant recovery whilst poverty levels soared. All this contributed to an economic climate in which most consumer goods categories saw weaker performance than in the past.

Competitive Landscape

Bayer Pharma, Alkaloid and PGT Healthcare led analgesics sales in Bosnia-Herzegovina in 2013, recording respective value shares of 18%, 16% and 16%. Alkaloid and PGT Healthcare's regional branch Pliva have been operating in Bosnia-Herzegovina for many years and continue to enjoy high levels of consumer loyalty. Bayer stormed into the area over the past decade, investing the most in advertising and brand image.

Industry Prospects

Over the forecast period, average value growth of analgesics is likely to be somewhat stronger but still within a similar range to that recorded during the review period. Analgesics is one of the most mature consumer health categories and is not likely to see major shifts in category performance over the forecast period. It is likely that most growth will be coming from less mature areas of the category, ie paediatric analgesics. Also, consumers are likely to shift between various analgesics types, driven by improvements in effectiveness, safety and convenience, and hence growing popularity of aspirin is expected.

View Full Report Details and Table of Contents

Report Overview

Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Bosnia-Herzegovina with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Analgesics industry in Bosnia-Herzegovina, our research will save you time and money while empowering you to make informed, profitable decisions.

The Analgesics in Bosnia-Herzegovina market research report includes:

- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volumes and values, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

- What is the market size of Analgesics in Bosnia-Herzegovina?
- What are the major brands in Bosnia-Herzegovina?
- Are combination products with acetaminophen still popular?

Reasons to Get this Report

- Gain competitive intelligence about market leaders

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Consumer Goods research reports at Fast Market Research

You may also be interested in these related reports:

- Analgesics in Israel
- Analgesics in Indonesia
- Analgesics in the United Kingdom
- Analgesics in South Korea
- Analgesics in India
- Analgesics in Ireland
- Analgesics in Bosnia-Herzegovina
- Analgesics in the US
- Analgesics in Bolivia
- Analgesics in Ukraine

Media Relations Contact

Bill Thompson
Director of Marketing
Fast Market Research, Inc.
800-844-8156
http://www.fastmr.com

View this press release online at: http://rwire.com/519589